trial
August 2, 2023 blogger academia, academic, agreement, analysis, analytics, benefit, Business, Business Analysis, cannabis, clinical, Cultivation & Growing, data, extraction, Federal, government, Growing, industry, Innovation, lab, laboratories, Laboratories & Analytics, laboratory, labs, Law, Legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicial Marijuana, medicinal, Medicine, Operations, preclinical, product, Product Development, quality, regulation, Regulations, regulatory, research, Retail, safety, state, Stop Smoking Marijuana, Stop Smoking Pot, Studies, Study, technology, test, Testing, transfer, trial, universities, University, weed, withdrawal
Universities across the country are working in all areas of research and development to advance cannabis cultivation, medicine, drug delivery and technology. But these innovations are collecting dust because the universities are not in the business of commercializing products in the marketplace. In 1980, the federal government passed a law that said universities that receive […]
academia, academic, agreement, analysis, analytics, benefit, Business, Business Analysis, cannabis, clinical, Cultivation & Growing, data, extraction, Federal, government, Growing, industry, Innovation, lab, laboratories, Laboratories & Analytics, laboratory, labs, Law, legal, legalization, Legalize, legislation, license, marijuana, market, Medical, medicinal, Medicine, Operations, preclinical, product, Product Development, quality, regulation, Regulations, regulatory, research, Retail, safety, state, Studies, Study, technology, test, Testing, transfer, trial, universities, University
December 9, 2022 blogger Affinity, analysis, analytics, bio, Business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, Growing, head, industry, lab, laboratories, laboratory, labs, Law, Legal, legalization, Legalize, legislation, license, marijuana, Medical, Medicial Marijuana, Medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, quality, regulation, regulatory, safety, state, Stop Smoking Marijuana, Stop Smoking Pot, Studies, Study, test, Testing, therapeutics, to, trial, weed, withdrawal, Zelira
Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organization, have completed enrollment […]
Affinity, analysis, analytics, bio, Business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, Growing, head, industry, lab, laboratories, laboratory, labs, Law, legal, legalization, Legalize, legislation, license, marijuana, Medical, Medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, quality, regulation, regulatory, safety, state, Studies, Study, test, Testing, therapeutics, to, trial, Zelira